In Part 1, we discussed the focused information clinicians need to quickly assess an anticoagulation patient’s health and a review of patient treatment plan trends. Here in part 2, we will discuss the many ways to identify patients who are at risk for drug interactions or re-admissions, and evidence-based guidelines that support dosing decisions.
Identify Patients at Risk
There are many ways to identify patients that require a bit of extra scrutiny. PCDS believes it is important that a clinician is immediately made aware of any patients with higher than normal levels of risk given their care plan. We further believe it is important that risk identifiers be objective and measurable. That is why AC has three validated survey instruments built into the application for easy access, execution as well as to clearly demonstrate the results of completed surveys when they indicate patients may be at risk.